Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of Success with Desmopressin in Nocturnal Enuresis
NCT06285006Recruiting
- Sponsor
- Al-Azhar University
- Start
- Feb 2024
- Primary completion
- May 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of desmopressin in nocturnal enuresis (NE), sponsored by Al-Azhar University. Primary endpoint: The number of episodes per week after desmopressin treatment. Started Feb 2024; status: recruiting.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT06285006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06285006.